Adverse Neurodevelopmental Outcomes Up for Moderate, Late Preemies
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Jan. 30, 2024 -- Children born moderately or late preterm have increased risks for adverse neurodevelopmental outcomes, including motor, cognitive, epileptic, visual, and hearing impairments, according to a study published online Jan. 24 in The BMJ.
Ayoub Mitha, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleagues conducted a nationwide cohort study in Sweden involving 1,281,690 liveborn singleton children without congenital malformations born at 32+0 to 41+6 weeks to assess long-term neurodevelopmental outcomes, diagnosed up to age 16 years.
During a median follow-up of 13.1 years, 75,311 liveborn singleton infants without congenital malformations had at least one diagnosis of any neurodevelopmental impairment (47.8 per 10,000 person-years). The researchers found that children born moderately or late preterm showed higher risks for any impairment compared with those born full term (hazard ratios, 1.73 and 1.30, respectively), as well as higher risks for motor, cognitive, epileptic, visual, and hearing impairments. The highest risks for neurodevelopmental impairments were seen from 32 weeks and decreased gradually until 41 weeks; risks were higher at 37 to 38 weeks than 39 to 40 weeks. Most associations remained stable in the sibling analysis, which included 349,108 participants, apart from gestational age and epileptic and hearing impairments, where no association was observed. Compared with those born full term, the risk was only higher for cognitive impairment among children born early term.
"Our findings support that preventing moderately or late preterm delivery may have implications for public health, and that higher risks faced by these groups of children and their families should not be underestimated," the authors write.
One author disclosed ties to Neobiomics, which provides dietary supplement solutions for infants.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-31 02:15
Read more
- Want to Slowly Cut Down on Dietary Salt? Here's How
- Ozempic, Wegovy Might Help Lower Alzheimer's Risk in People With Diabetes
- AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
- Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination
- Diabetes & Kidney Trouble Can Bring Heart Disease Decades Earlier
- People's Brains Now Process Texts Almost as Quickly as Pictures
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions